AEON
AEON Biopharma·AMEX
--
--(--)
--
--(--)
6.95 / 10
Outperform
Analyst consensus is overwhelmingly bullish, with a single Strong Buy rating and a 100% historical win rate. Fund‑flow score is 6.97/10, showing solid inflows from small and medium investors but negative trends for large blocks. Sentiment remains positive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
David BoucheyStrong Buy
Date2025-10-08
InstitutionAegis Capital
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of AEON?
- AEON holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.95/10 (Outperform).
